期刊文献+

白细胞介素1A多态性与神经胶质瘤的相关性 被引量:1

Association between interleukin-1A polymorphisms and risk of glioma
下载PDF
导出
摘要 目的探讨白细胞介素1A(IL-1A)多态性与神经胶质瘤的相关性。方法采用聚合酶链反应-限制性片段长度多态性检测154例神经胶质瘤患者和195例正常对照组IL-1A多态性。结果 IL-1A+4845G/T位点:与GG基因型相比,GT/TT基因型显著增加了神经胶质瘤的发病风险(GT/TT与GG相比:χ2=5.94,P=0.015)。与G等位基因相比,T等位基因显著增加了神经胶质瘤的发病风险(χ2=5.97,P=0.015)。未发现IL-1A-889C/T多态性频率分布在对照组和神经胶质瘤组之间存在显著差异。根据神经胶质瘤病理分级进行亚组分析,未发现IL-1A-889C/T和+4845G/T多态性与病理分级存在明显相关性(P>0.05)。结论 IL-1A+4845G/T多态性与神经胶质瘤的发病有关。 Objective To investigate the association between interleukin-1A (IL-1A)polymorphisms and risk of glioma.Methods The IL-1A polymorphisms were genotyped in 154 patients with glioma and 195 healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay.Results The GT/TT genotypes of IL-1A+4845G/T polymorphism were associated with a significantly increased risk of glioma compared with the GG genotype (GT/TT vs.GG:χ^2 =5.94,P =0.015).Similarly,the T allele of IL-1A +4845G/T polymorphism was associated with a significantly increased risk of glioma compared with the G allele (χ^2 =5.97,P =0.015).There was no difference in the distribution of the IL-1A-889C/T polymorphism between cases and controls.After subgroup analysis according to histophthological grades,no significant association was observed between IL-1A-889C/T and + 4845G/T polymorphisms and histophthological grades (P 〉0.05).Conclusion IL-1A +4845G/T polymorphism is related to the risk of glioma.
作者 岩亮 舒云
出处 《中国实验诊断学》 2014年第9期1446-1448,共3页 Chinese Journal of Laboratory Diagnosis
关键词 白细胞介素1A 多态性 神经胶质瘤 Interleukin-1A Polymorphism Glioma
  • 相关文献

参考文献10

  • 1Apte RN,Voronov E. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy[J]. Immunol Rev, 2008,222:222.
  • 2White KL,Schildkraut JM,Palmieri RT,et al. Ovarian cancer risk associated with inherited inflammation-related variants [J]. Cancer Res, 2012,72(5) : 1064.
  • 3Yang ZH, Dai Q, Zhong L, et al. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharynge al carcinoma[J]. Mol Carcinog, 2011,50 (3) : 208.
  • 4Saenz-Lopez P, Carretero R, Cozar JM, et al. Genetic polymor- phisms of RANTES,IL1-A,MCP-1 and TNF A genes in patients with prostate cancer[J]. BMC Cancer, 2008,8,382.
  • 5Abazis-Stamboulieh D,Oikonornou P, Papadoulis N, et al. Associ ation of interleukin 1A,interleukin'lB and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma [J]. Leuk Lymphoma,2007,48(11):2196.
  • 6Kamangar F,Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland) [J]. Cancer Causes Control,2006,17(1) :117.
  • 7Snoussi K, Strosberg AD, Bouaouina N, et al. Genetic variation in pro-inflammatory cytokines (interleukin lbeta,interleukin-lalpha and interleukin-6) associated with the aggressive forms,survival, and relapse prediction of breast carcinoma [J]. Eur Cytokine Netw,2005,16(4) :253.
  • 8Wang B, Zhou S, Wang J, et al. Lack of association between inter leukin-la gene (IL-la) C (-889) T variant and polycystic ovary syndrome in Chinese women[J]. Endocrine, 2009,35 (2) : 198.
  • 9Archana PM,Salman AA, Kumar TS, et al. Association between interleukin-1 gene polymorphism and severity of chronic periodontiffs in a south Indian population group[J]. J Indian Soc Periodontol, 2012,16(2) : 174.
  • 10李刚,邓林.白细胞介素在人脑胶质瘤基因免疫治疗中的研究[J].中华神经外科疾病研究杂志,2009,8(5):385-388. 被引量:2

二级参考文献22

  • 1Ohgaki H. Epidemiology of Brain Tumors [ J ]. Methods Mol Biol,2009, 472:323 - 342.
  • 2Bryan L, Paugh BS, Kapitonov D, et al. Sphingosine-1-phosphate and interleukin-1 inde- pendently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness [J]. Mol Cancer Res, 2008, 6(9) : 1469 -1477.
  • 3Gu J, Li G, Sun T, et al. Blockage of the STA33 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells [ J]. J Neurooncol, 2008, 89( 1 ) : 9 - 17.
  • 4Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma [ J ]. Blood, 2008, 111(7) : 3701 -3713.
  • 5Shouda T, Hiraoka K, Komiya S, et al. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells [J]. Cancer Lett, 2006, 231 (2) : 176 - 184.
  • 6Leu CM, Wong FH, Chang C, et al. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways [J]. Oncogene, 2003, 22(49): 7809-7818.
  • 7Chen RH, Chang MC, Su YH, et al. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription-3 pathways [ J]. J Biol Chem, 1999, 274(33) : 23013 -23019.
  • 8Loeffler S, Fayard B, Weis J, et al. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1[ J]. Int J Cancer, 2005, 115(2): 202-213.
  • 9de la Iglesia N, Konopka G, Lim KL, et al. Deregulation of a STAT3- interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness [ J]. J Neurosci, 2008, 28 (23): 5870 - 5878.
  • 10Kioi M, Husain SR, Croteau D, et al. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy [ J ]. Technol Cancer Res Treat, 2006, 5 (3) : 239 - 250.

共引文献1

同被引文献58

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部